IP Library › Granted Patent US 9,795,565
Granted Patent B2
US 9,795,565 · App. 12/739,389 · Granted Oct 24, 2017

Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant

Inventors: Laurent Dupuis (Reims, FR); Jérôme Gaucheron (Castres, FR); Olivier Braun (Castres, FR)
Assignee: Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC
A61K9/127A61K9/0019A61K47/32A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,565
App. No.
12/739,389
Granted
Oct 24, 2017
Kind
B2
Abstract

Method for preparing a vaccine, comprising—a step a) of preparing an adjuvant composition by dispersing, in a physiologically acceptable aqueous solution, at least one inverse latex or a powder of polymer resulting from the atomization of said inverse latex; —a step b) of mixing the composition obtained in step a) into an antigenic medium, intended to form a vaccine composition.

Claims (17)

1. A method for preparing a vaccine, said method comprising:

a step a) of preparing an adjuvant composition by dispersing, in a physiologically acceptable aqueous solution, at least one inverse latex or a powder of polymer resulting from the atomization of said inverse latex;

wherein the inverse latex comprises at least one branched or crosslinked, anionic polyelectrolyte comprising a totally or partially salified acrylic acid homopolymer and further comprising a step a) (i) of adding one or more water soluble metal cation organic salts

a step b) of mixing the composition obtained in step a) into an antigenic medium comprising an antigen, to form a composition capable of eliciting an immune response to the antigen upon administration to a subject.

2. The method of claim 1 , wherein during step a) at least one additional immunostimulant substance is added.

3. The method of claim 1 , wherein step b) comprises mixing 10% to 20% of the preparation obtained in step a) with 80% to 90% of the antigenic medium.

4. The method of claim 1 , further comprising, during step b):

a step of adding at least one immunostimulant chosen from saponins, animal and/or plant and/or mineral and/or synthetic oils, surfactants, aluminum hydroxide, lecithins and lecithin derivatives.

5. The method of claim 2 , wherein step b) comprises mixing 10% to 20% of the preparation obtained in step a) with 80% to 90% of the antigenic medium.

6. The method of claim 2 , further comprising, during step b):

a step of adding at least one immunostimulant chosen from saponins, animal and/or plant and/or mineral and/or synthetic oils, surfactants, aluminum hydroxide, lecithins and lecithin derivatives.

7. The method of claim 3 , further comprising, during step b):

a step of adding at least one immunostimulant chosen from saponins, animal and/or plant and/or mineral and/or synthetic oils, surfactants, aluminum hydroxide, lecithins and lecithin derivatives.

8. The method of claim 1 , wherein the one or more water-soluble metal cation organic salts comprises manganese gluconate.

9. The method of claim 1 , wherein the formed composition is a vaccine.

10. The method of claim 1 , wherein the formed composition is a vaccine.

11. The method of claim 8 , wherein the formed composition is a vaccine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2010
From: DUPUIS, LAURENT; GAUCHERON, JEROME; BRAUN, OLIVIER
To: SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
Reel/Frame 024275/0623 →
Priority Claims (1)
FR 07 58542 · Oct 24, 2007 · national
Continuity (1)
Related Publication 20100233196A1 · Sep 16, 2010